This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mark Your Calendar for Next Year's Event!
May 9-12, 2022Hynes Convention Center, Boston

Justin Murray, PhD
Senior Principal Scientist, Selection & Modality Engineering at Amgen, Inc.

Profile

Justin received his BSc in Chemistry from the Colorado School of Mines. He received his PhD from the University of Wisconsin - Madison under the direction of Prof. Sam Gellman for research on beta-peptide inhibitors of protein-protein interactions. He joined the Peptide Research & Discovery group at Amgen in 2006 and focused his research on disulfide-rich peptide inhibitors of ion channels and developed his interests in high-throughput synthesis, laboratory automation, and conjugation technologies. Now in the Selection & Modality Engineering group, Justin is working to establish oligonucleotide therapeutics as a new modality for Amgen.

Agenda Sessions

  • ROOM 205A: Identification and Optimization of a Minor Allele-specific siRNA to Prevent PNPLA3 I148M-driven Nonalcoholic Fatty Liver Disease

    10:45am

Speakers at this event